Metraipolis › archive › dc_e9ee916fdd9f

Beyond glycemic control: the cardiac and hepatic benefits of SGLT2 and DPP-4 inhibitors in mitigating chronic cadmium-induced inflammation,… — Europe PMC PMID:41648790

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41648790
DOI
10.3389/fphys.2025.1752370
License (as archived)
solo-consultazione
Archived
2026-11-06T15:09:48.067Z
SHA-256 of the archived text
fd51101e11d1e683ca47cda2e5e1463b84f041f6377890c9a3e41c55a26fb1d5
Stable URL of this page
https://metraipolis.com/documento/dc_e9ee916fdd9f

How to cite

Beyond glycemic control: the cardiac and hepatic benefits of SGLT2 and DPP-4 inhibitors in mitigating chronic cadmium-induced inflammation,… — Europe PMC PMID:41648790 — Europe PMC (en), https://europepmc.org/article/MED/41648790 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e9ee916fdd9f (Metraipolis archive dc_e9ee916fdd9f, sha256 fd51101e11d1e683ca47cda2e5e1463b84f041f6377890c9a3e41c55a26fb1d5)
BibTeX
@misc{dce9ee916fdd9f,
  title = {Beyond glycemic control: the cardiac and hepatic benefits of SGLT2 and DPP-4 inhibitors in mitigating chronic cadmium-induced inflammation,… — Europe PMC PMID:41648790},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41648790},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e9ee916fdd9f; sha256 fd51101e11d1e683ca47cda2e5e1463b84f041f6377890c9a3e41c55a26fb1d5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41648790. Agents can read the archived copy with the MCP tool read_document.